首页> 外文OA文献 >Engineering, overexpression, purification and analytical applications of recombinant bioluminescent reporters.
【2h】

Engineering, overexpression, purification and analytical applications of recombinant bioluminescent reporters.

机译:重组生物发光报告基因的工程,过表达,纯化和分析应用。

摘要

The initial project entailed the construction of a plasmid suitable for bacterial expression of the in vivo biotinylated aequorin photoprotein. The plasmid contained a biotin-acceptor coding sequence fused in-frame with the apoaequorin gene as well as the birA gene, encoding biotin protein ligase (BPL), responsible for post-translational biotinylation. The use of the biotin tag facilitated (a) the purification of aequorin from the crude cell extract using an avidin resin and (b) the direct complexation of aequorin with streptavidin for utilization as a reporter molecule. Streptavidin-biotinylated aequorin complexes were used for the quantification of biotinylated hybrids in a hybridization assay, with high detectability and reproducibility. Yields of in vivo biotinylated aequorin from one liter of culture were sufficient for 300 000 hybridization assays. The goal of the second project was to create novel aequorin photoproteins with improved luminescent activity over the native protein, through directed molecular evolution of the apoaequorin gene. Random mutagenesis was accomplished through repeated rounds of DNA shuffling, cloning and expression of mutant proteins, followed by screening and selection of regenerated mutants. Increased ratios of luminescent signals to the mass of total soluble protein were compared as criteria for mutant selection after five rounds of shuffling. Initial data indicated three mutants exhibited 20--60 fold higher luminescence in crude samples. Comparisons utilizing purified proteins indicated the mutant aequorins had identical luminescent activity to the native protein, and selection possibly favoured mutations allowing improved solubility of the overexpressed protein during extraction rather than higher luminescence quantum yield. The final project involved the Gaussia princeps luciferase (GLuc), which has recently been cloned as the smallest known coelenterazine-using luciferase. Presently, there are no analytical studies using GLuc as a bioluminescent reporter. Beginning with GLuc cDNA, a plasmid encoding a biotin acceptor peptide-GLuc fusion protein was constructed. This allowed overexpression in E. coli and purification by avidin affinity chromatography. The light emission of purified Gluc was studied at various coelenterazine concentrations to establish the detectability of the new reporter, which was found to reach attomole levels. Furthermore, the complexation of biotinylated GLuc with streptavidin was used as a detection reagent in a microtiter well-based, bioluminometric DNA hybridization assay. Source: Dissertation Abstracts International, Volume: 64-01, Section: B, page: 0196. Adviser: K. Taylor. Thesis (Ph.D.)--University of Windsor (Canada), 2002.
机译:最初的项目需要构建适合于细菌表达体内生物素化水母发光蛋白光蛋白的质粒。质粒包含与载脂蛋白母基基因以及birA基因框内融合的生物素受体编码序列,编码生物素蛋白连接酶(BPL),负责翻译后生物素化。生物素标签的使用促进(a)使用抗生物素蛋白树脂从粗细胞提取物中纯化水母发光蛋白,以及(b)水母发光蛋白与链霉亲和素的直接络合以用作报道分子。链霉亲和素-生物素化的水母发光蛋白复合物用于杂交测定中生物素化的杂合体的定量,具有很高的可检测性和可重复性。一升培养物中体内生物素化水母发光蛋白的产量足以进行300 000杂交测定。第二个项目的目标是通过定向载脂蛋白水母基因的分子进化来创建新型的水母发光蛋白光蛋白,其发光活性高于天然蛋白质。随机诱变是通过重复几轮DNA改组,克隆和表达突变蛋白,然后筛选和选择再生突变体来完成的。经过五轮改组后,比较了发光信号与总可溶性蛋白质量增加的比率作为突变选择的标准。初始数据表明,三个突变体在粗样品中的发光强度提高了20--60倍。利用纯化蛋白进行的比较表明,突变体水母发光蛋白具有与天然蛋白相同的发光活性,选择可能偏爱的突变可以提高提取过程中过表达蛋白的溶解度,而不是更高的发光量子产率。最终项目涉及高斯普林斯荧光素酶(GLuc),该酶最近已被克隆为已知最小的腔肠素使用荧光素酶。目前,尚无使用GLuc作为生物发光报告基因的分析研究。从GLuc cDNA开始,构建了编码生物素受体肽-GLuc融合蛋白的质粒。这允许在大肠杆菌中过表达并通过亲和素亲和层析纯化。在各种腔肠素浓度下研究了纯化的Gluc的发光,以建立新报告基因的可检测性,发现其达到了attomole的水平。此外,生物素化的GLuc与链霉亲和素的复合物在基于微量滴定仪的生物发光DNA杂交测定中用作检测试剂。资料来源:国际学位论文摘要,卷:64-01,科目:B,页面:0196。顾问:K. Taylor。论文(博士学位)-温莎大学(加拿大),2002。

著录项

  • 作者

    Verhaegen Monique Elise.;

  • 作者单位
  • 年度 2002
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号